相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reversing the Epithelial-Mesenchymal Transition in Metastatic Cancer Cells Using CD146-Targeted Black Phosphorus Nanosheets and a Mild Photothermal Treatment
Jinyuan Liu et al.
ACS NANO (2022)
Human transcription factor protein interaction networks
Helka Goos et al.
NATURE COMMUNICATIONS (2022)
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
Andre E. Nel et al.
ACS NANO (2022)
Double-drug loading upconversion nanoparticles for monitoring and therapy of a MYC/BCL6-positive double-hit diffuse large B-cell lymphoma
Yulu Yang et al.
BIOMATERIALS (2022)
Gold-Nanoparticle-Conjugated Citrate Inhibits Tumor Necrosis Factor-' Expression via Suppression of Nuclear Factor Kappa B (NF-KB) Activation in Breast Cancer Cells
Abdullah S. M. Aljohani et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2022)
The Progress and Promise of RNA Medicine?An Arsenal ofTargeted Treatments
Janet M. Sasso et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Advancement of cancer immunotherapy using nanoparticles-based nanomedicine
Vemana Gowd et al.
SEMINARS IN CANCER BIOLOGY (2022)
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
Qingyuan Cheng et al.
JOURNAL OF OVARIAN RESEARCH (2022)
DNA- and RNA-Binding Proteins Linked Transcriptional Control and Alternative Splicing Together in a Two-Layer Regulatory Network System of Chronic Myeloid Leukemia
Chuhui Wang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Functionalized-DNA nanostructures as potential targeted drug delivery systems for cancer therapy
Ajay Kumar et al.
SEMINARS IN CANCER BIOLOGY (2022)
Targeting transcription cycles in cancer
Stephin J. Vervoort et al.
NATURE REVIEWS CANCER (2022)
Application of ZnO/CNT@Fe3O4 nanocomposite in amplifying the anti-leukemic effects of Imatinib: a novel strategy to adjuvant therapy in chronic myeloid leukemia
Amir-Mohammad Yousefi et al.
BIOMEDICAL MATERIALS (2021)
STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer
Romulo S. Cavalcante et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol
Mona A. Abdelmoneem et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models
Keith T. Schmidt et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective
Yongquan Tang et al.
PHARMACEUTICS (2021)
Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment
Shan Gao et al.
ACS NANO (2021)
Urinary exosomes-based Engineered Nanovectors for Homologously Targeted Chemo-Chemodynamic Prostate Cancer Therapy via abrogating EGFR/AKT/NF-kB/IkB signaling
Shaojun Pan et al.
BIOMATERIALS (2021)
Curcumin-Loaded Nanoparticles Impair the Pro-Tumor Activity of Acid-Stressed MSC in an In Vitro Model of Osteosarcoma
Gemma Di Pompo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Mesoporous silica nanoparticles inflame tumors to overcome anti-PD-1 resistance through TLR4-NFκB axis
Mayu Sun et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Christiana M. Neophytou et al.
CANCERS (2021)
Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis
Zeyaul Islam et al.
FRONTIERS IN ONCOLOGY (2021)
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Shreelaxmi Gavas et al.
NANOSCALE RESEARCH LETTERS (2021)
MYC protein interactors in gene transcription and cancer
Corey Lourenco et al.
NATURE REVIEWS CANCER (2021)
Transcription factors in SOX family: Potent regulators for cancer initiation and development in the human body
Prasann Kumar et al.
SEMINARS IN CANCER BIOLOGY (2020)
Ras-Mediated Activation of NF-κB and DNA Damage Response in Carcinogenesis
Anas Ahmad et al.
CANCER INVESTIGATION (2020)
Alginate based tamoxifen/metal dual core-folate decorated shell: Nanocomposite targeted therapy for breast cancer via ROS-driven NF-κB pathway modulation
Omar M. Ibrahim et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
Silvia Belluti et al.
CELLS (2020)
Understanding the Monoclonal Antibody Involvement in Targeting the Activation of Tumor Suppressor Genes
Rakesh Kumar Mishra et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Catcher in the rel: Nanoparticles-antibody conjugate as NF-κB nuclear translocation blocker
Yi-Ping Chen et al.
BIOMATERIALS (2020)
ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice
Qiyue Wang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' c-Myc for the treatment of pancreatic cancer
Aishwarya Saraswat et al.
NANOMEDICINE (2020)
Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition
Hailun Zheng et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Fibrinolytic tissue plasminogen activator installed redox-active nanoparticles (t-PA@iRNP) for cancer therapy
Ting Mei et al.
BIOMATERIALS (2020)
One-pot synthesis of a microporous organosilica-coated cisplatin nanoplatform for HIF-1-targeted combination cancer therapy
Xiaojuan Zhang et al.
THERANOSTICS (2020)
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
Alison K. Esser et al.
THERANOSTICS (2020)
Decoration of Anti-CD38 on Nanoparticles Carrying a STAT3 Inhibitor Can Improve the Therapeutic Efficacy Against Myeloma
Yung-Hsing Huang et al.
CANCERS (2019)
Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
Chin-Yap Loh et al.
FRONTIERS IN ONCOLOGY (2019)
A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy
Mohammad A. I. Al-Hatamleh et al.
JOURNAL OF ONCOLOGY (2019)
Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia
Noureldien H. E. Darwish et al.
MOLECULES (2019)
Gold nano-particles (AuNPs) carrying miR-326 targets PDK1/AKT/c-myc axis in hepatocellular carcinoma
Yichao Mo et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Highlights in Resistance Mechanism Pathways for Combination Therapy
Joao M. A. Delou et al.
CELLS (2019)
JQ1-Loaded Polydopamine Nanoplatform Inhibits c-MYC/Programmed Cell Death Ligand 1 to Enhance Photothermal Therapy for Triple-Negative Breast Cancer
Ying Tian et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes
Morten Norgaard Andersen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma
Xi Cao et al.
ACTA PHARMACEUTICA SINICA B (2019)
ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling
Yongquan Huang et al.
THERANOSTICS (2019)
Fabrication and characterization of solid lipid nano-formulation of astraxanthin against DMBA-induced breast cancer via Nrf-2-Keap1 and NF-kB and mTOR/Maf-1/PTEN pathway
Tao Sun et al.
DRUG DELIVERY (2019)
Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer
Gang Chen et al.
ACS NANO (2018)
Probing Cellular Processes Using Engineered Nanoparticles
Md Nazir Hossen et al.
BIOCONJUGATE CHEMISTRY (2018)
Inorganic kernel - Supported asymmetric hybrid vesicles for targeting delivery of STAT3-decoy oligonucleotides to overcome anti-HER2 therapeutic resistance of BT474R
Kai Shi et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Delivery of NF-kappa B shRNA using carbamate-mannose modified PEI for eliminating cancer stem cells
Xiyu Ke et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer
Sophia A. Shahin et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Lan Thi Hanh Phi et al.
STEM CELLS INTERNATIONAL (2018)
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
Longfa Kou et al.
FRONTIERS IN PHARMACOLOGY (2018)
Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway
Donglai Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Abnormal microRNA expression in the course of hematological malignancies
Agnieszka Szymczyk et al.
CANCER MANAGEMENT AND RESEARCH (2018)
CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α
Xi Tian et al.
CANCER RESEARCH (2017)
Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer
Anup Jose et al.
JOURNAL OF DRUG TARGETING (2017)
Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles
Suman Labala et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Preparation and characterization of lipid nanoparticle/pDNA complexes for STAT3 downregulation and overcoming chemotherapy resistance in lung cancer cells
Mustafa Kotmakci et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond
Samir Mitragotri et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Inhibition of prostate cancer RM1 cell growth in vitro by hydroxyapatite nanoparticle-delivered short hairpin RNAs against Stat3
Zuowen Liang et al.
MOLECULAR MEDICINE REPORTS (2017)
Self-Associating Poly(ethylene oxide)-block-poly(α-carboxyl-ε-caprolactone) Drug Conjugates for the Delivery of STAT3 Inhibitor JSI-124: Potential Application in Cancer Immunotherapy
Shyam M. Garg et al.
MOLECULAR PHARMACEUTICS (2017)
Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models
Cai M. Roberts et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
Renumathy Dhanasekaran et al.
Oncotarget (2017)
Transforming growth factor-: A therapeutic target for cancer
Sulsal Haque et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition
Zu-Qi Zuo et al.
BIOMATERIALS (2016)
Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer
Elizabeth Pham et al.
CANCER RESEARCH (2016)
Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma
Suman Labala et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis
Tieshan Yang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Cancer stem cell signaling pathways
William H. Matsui
MEDICINE (2016)
TTF1, in the Form of Nanoparticles, Inhibits Angiogenesis, Cell Migration and Cell Invasion In Vitro and In Vivo in Human Hepatoma through STAT3 Regulation
Bin Xiao et al.
MOLECULES (2016)
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
Andrew J. Clark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds
Muthu K. Shanmugam et al.
SEMINARS IN CANCER BIOLOGY (2016)
Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis
Chien-Ju Lin et al.
ONCOTARGET (2016)
Trimodal Therapy: Combining Hyperthermia with Repurposed Bexarotene and Ultrasound for Treating Liver Cancer
Santosh K. Misra et al.
ACS NANO (2015)
Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo
Zichao Luo et al.
BIOMATERIALS (2015)
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer
Sarah J. Conley et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
Michael D. Brooks et al.
CELL STEM CELL (2015)
Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma
Deepti Soodgupta et al.
MOLECULAR CANCER THERAPEUTICS (2015)
RNA Interference Using c-Myc-Conjugated Nanoparticles Suppresses Breast and Colorectal Cancer Models
Naveen K. Tangudu et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer
Giuseppina Salzano et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Ultrasound Targeted Microbubble Destruction-Mediated Delivery of a Transcription Factor Decoy Inhibits STAT3 Signaling and Tumor Growth
Jonathan A. Kopechek et al.
THERANOSTICS (2015)
RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
James Finlay et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Translational Impact of Nanoparticle-Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer
Elizabeth Pham et al.
CLINICAL CANCER RESEARCH (2015)
Targeting Transcription Factors in Cancer
Anand S. Bhagwat et al.
TRENDS IN CANCER (2015)
NanoScript: A Nanoparticle-Based Artificial Transcription Factor for Effective Gene Regulation
Sahishnu Patel et al.
ACS NANO (2014)
Large differences in global transcriptional regulatory programs of normal and tumor colon cells
David Cordero et al.
BMC CANCER (2014)
Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
Wei Wang et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Preparation and evaluation of nanoparticles loading plasmid DNAs inserted with siRNA fragments targeting c-Myc gene
Tao Ma et al.
PHARMACEUTICAL BIOLOGY (2014)
Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo
Jayeeta Das et al.
TOXICOLOGY LETTERS (2014)
Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice
Huan Meng et al.
ACS NANO (2013)
Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy
Yuan Zhang et al.
BIOMATERIALS (2013)
Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles
Jianan Shen et al.
BIOMATERIALS (2013)
Regulation of autophagy by stress-responsive transcription factors
Federico Pietrocola et al.
SEMINARS IN CANCER BIOLOGY (2013)
Dysregulation of the basal RNA polymerase transcription apparatus in cancer
Megan J. Bywater et al.
NATURE REVIEWS CANCER (2013)
Cancer stem cells
Zuoren Yu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells
Wen-Pin Su et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo
Zuo-Wen Liang et al.
ASIAN JOURNAL OF ANDROLOGY (2011)
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Christine L. Chaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine
Aws Alshamsan et al.
BIOMATERIALS (2010)
Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer
Yunching Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Development of a Poly(D,L-lactic-co-glycolic acid) Nanoparticle Formulation of STAT3 Inhibitor JSI-124: Implication for Cancer Immunotherapy
Leila Molavi et al.
MOLECULAR PHARMACEUTICS (2010)
NFAT, immunity and cancer: a transcription factor comes of age
Martin R. Mueller et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems
Bifeng Pan et al.
NANOTECHNOLOGY (2009)
Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors
Ommoleila Molavi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
分享论文
